Jonathan Cotliar

Insider Reports History

Entity
Individual
Location
C/O Lifesci Acquisition II Corp., 250 W 55 Th Street, #3401, New York, New York
Signature
/s/ Christine Pellizzari, Attorney-in-fact for Jonathan Cotliar
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Cotliar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Science 37 Holdings, Inc. Chief Medical Officer Common Stock 0 $0 $5.75 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Chief Medical Officer Restricted Stock Units 0 $0 $5.75 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Chief Medical Officer Earn-Out Right 0 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Chief Medical Officer Stock Option 0 Mar 12, 2024 Direct

Insider Reports Filed by Jonathan Cotliar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNCE Science 37 Holdings, Inc. Mar 12, 2024 5 -314,841 4 Mar 12, 2024 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Aug 12, 2023 3 -35,129 4 Aug 15, 2023 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Apr 28, 2023 3 0 4 May 2, 2023 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Aug 12, 2022 1 0 4 Aug 16, 2022 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Apr 20, 2022 4 26,012 4 Apr 21, 2022 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Jan 7, 2022 1 0 4 Jan 11, 2022 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Oct 25, 2021 10 41,434 4 Feb 25, 2022 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Oct 6, 2021 2 0 4 Oct 12, 2021 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Oct 6, 2021 4 0 4 Oct 8, 2021 Chief Medical Officer
SNCE Science 37 Holdings, Inc. Oct 6, 2021 0 0 3 Oct 8, 2021 Chief Medical Officer